13F-HR filed by STEMPOINT CAPITAL LP
STEMPOINT CAPITAL LP filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-13, with 54 holding rows worth $334,017,222.
- Accession
- 0001420506-24-002386
- Filer
- CIK 1952142
- Filed
- 2024-11-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A holdings report, 58 entries on the cover page, a total value of $334,017,222 stated on the cover page (in dollars after the unit check, H1), rows summing to $334,017,222 with VALUE read as dollars as filed, 13F file number 028-23724. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 1,731,191 | $33,325,427 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 2,769,819 | $31,963,711 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 421,222 | $21,044,251 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 671,001 | $19,130,239 | dollars as filed | |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 1,778,318 | $16,538,357 | dollars as filed | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 1,481,809 | $15,825,720 | dollars as filed | |
| Bristol-Myers Squibb Company | 110122108 | COM | 275,303 | $14,244,177 | dollars as filed | |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 1,554,586 | $13,213,981 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 213,815 | $10,925,947 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 216,440 | $10,815,507 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 174,034 | $10,013,916 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 2,616,602 | $9,498,265 | dollars as filed | |
| INCYTE CORP COM | 45337C102 | Stock | 129,490 | $8,559,289 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 282,050 | $8,216,117 | dollars as filed | |
| Day One Biopharmaceuticals Inc | 23954D109 | Common Stock | 506,978 | $7,062,204 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 1,317,854 | $6,497,020 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 123,177 | $6,219,207 | dollars as filed | |
| CABALETTA BIO INC | 12674W109 | COMMON STOCK | 1,278,444 | $6,034,256 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 449,735 | $5,131,476 | dollars as filed | |
| KEROS THERAPEUTICS INC COM | 492327101 | Stock | 86,930 | $5,048,025 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 60,076 | $5,016,947 | dollars as filed | |
| VISTAGEN THERAPEUTICS INC | 92840H400 | COM | 1,846,792 | $4,900,565 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 203,015 | $4,561,747 | dollars as filed | |
| Tscan Therapeutics Inc | 89854M101 | COM | 860,951 | $4,287,536 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 1,044,168 | $4,239,322 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 132,703 | $4,204,031 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 449,321 | $3,747,337 | dollars as filed | |
| PERSPECTIVE THERAPEUTICS INC | 46489V302 | COMMON STOCK | 238,084 | $3,178,421 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 850,210 | $3,120,271 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 73,299 | $3,075,626 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 241,984 | $3,073,197 | dollars as filed | |
| VIGIL NEUROSCIENCE INC | 92673K108 | COM | 743,719 | $2,528,645 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 300,000 | $2,460,000 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 94,885 | $2,415,772 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 49,415 | $2,244,923 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 182,918 | $2,191,358 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 41,268 | $2,162,031 | dollars as filed | |
| HELIX ACQUISITION CORP II | G4444H101 | CL A ORD SHS | 200,000 | $2,089,980 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 15,014 | $1,875,098 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 942,857 | $1,725,428 | dollars as filed | |
| PERCEPTIVE CAPITAL SOLUTIONS | G70077105 | CL A ORD SHS | 150,000 | $1,503,000 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 55,523 | $1,427,496 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 93,638 | $1,424,234 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 48,918 | $1,369,215 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 83,662 | $1,337,755 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 50,000 | $1,299,000 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 14,464 | $763,699 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 16,654 | $755,259 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 56,287 | $618,876 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 19,900 | $531,131 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 230,000 | $381,750 | dollars as filed | call |
| IMMUNOVANT INC | 45258J102 | COM | 200,000 | $112,500 | dollars as filed | call |
| Applied Therapeutics Inc | 03828A101 | Common Stock | 251,600 | $75,480 | dollars as filed | call |
| ARCUTIS BIOTHERAPEUTICS INC | 03969K108 | COM | 250,000 | $12,500 | dollars as filed | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-002386 | this filing | 2024-11-13 | acceptance time not in the bulk data set |